SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026

SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII) , a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the advanced SSi Mantra surgical robotic system (the “SSi Mantra”) will be showcased at the 2026 Society of Robotic Surgery Annual Meeting (“SRS 2026”) in Hollywood, Florida, on July 23 - 26, 2026. The SSi Mantra will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the event. The livestreamed robotic telesurgery, a partial nephrectomy, will be performed remotely by Dr. Amitabh Singh from SS Innovations’ headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi, India. Additionally, the Company’s Chairman and Chief Executive Officer, Dr. Sudhir Srivastava, will be speaking at SRS 2026. Dr. Srivastava is scheduled to participate in multiple breakout sessions, including: Cardiac Telesurgery with the SSi Mantra (speaker) SSi Mantra Focus Sessions (speaker) Scaling Robotic Surgery for Global Access (speaker) Soft Tissue Robotics Update from Asia (panelist) Regulatory Frameworks Enabling Telesurgery (panelist) Industry Perspectives (panelist) Global and Military Sessions (panelist) Dr. Srivastava commented: “We look forward to showcasing our advanced SSi Mantra surgical robotic system next week in Florida at the Society of Robotic Surgery Annual Meeting, the premier gathering of innovators shaping the future of robotic surgery. This influential forum provides us with a prime opportunity to highlight the SSi Mantra’s cutting-edge surgical robotic technology, differentiated features, user friendliness, training capabilities, and cost efficiency. During this year’s event, I will be participating as a speaker or panelist in several industry focus sessions and will continue to share SS Innovations’ mission of democratizing global access to advanced surgical robotic care.” As of July 6, 2026, the cumulative number of multi-specialty procedures completed with the SSi Mantra surgical robotic system totaled 12,375, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries. Approximately 2,100 physicians have been trained on the SSi Mantra, which has been utilized to perform over 170 different types of procedures. About SS Innovations SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.